Author

E. Barragan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. F. Flemban· 1 shared A. Sempere· 1 shared C. Bonifer· 1 shared C. Botella· 1 shared C. Garcia· 1 shared C. Gil· 1 shared C. R. J. Ward· 1 shared C. Sargas· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. F. Flemban

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A heterozygous CEBPA mutation disrupting the bZIP domain causes MDS disease progression

R. Almaghrabi, Y. Alyayhawi, P. Keane, C. R. J. Ward, R. Bayley, C. Sargas, P. Menendez, G. J. Murphy, T. Sobahy, M. A. Baghdadi, A. F. Flemban, S. Kabrah, I. Akerman, M. Raghavan, E. Barragan, , P. Garcia

This study shows a heterozygous CEBPA mutation in the bZIP domain causes MDS progression by altering chromatin structure and clonal composition, using patient-derived iPSCs.

bioRxiv · Jul 24, 2023Cancer Biology

Identification of leukemia-associated immunophenotypes by database-guided flow cytometry provides a highly sensitive and reproduciblestrategy for the study of measurable residual disease in acutemyeloblastic leukemia

P. Pinero, M. Morillas, N. Gutierrez, E. Barragan, E. Such, J. Brena, C. Gil, C. Garcia, C. Botella, J. M. Gonzalez-Navajas, P. Zapater, P. Montesinos, A. Sempere, F. Tarin

This study identifies leukemia-associated immunophenotypes using database-guided flow cytometry, enabling sensitive and reproducible monitoring of measurable residual disease in acute myeloid leukemia.

bioRxiv · Jul 12, 2022 · PreprintCancer Biology